Critique: Kennedy Is Driving a Vast Inquiry Into Vaccines, Despite His Public S…

Source: nytimes
Authors: The reporters cover health policy, reported from Washington.
URL: https://www.nytimes.com/2026/05/11/health/kennedy-vaccine-safety.html

What the article reports

Health Secretary Robert F. Kennedy Jr. is secretly directing a broad, multi-agency research push to find evidence linking vaccines to chronic disease, autism, and other conditions, according to six anonymous sources. The effort, led by biostatistician Martin Kulldorff and estimated to cost $40–50 million through the CDC alone, is examining vaccinated-vs.-unvaccinated comparisons and revisiting thimerosal, even as career scientists raise methodological and mission concerns. The White House has publicly muzzled Kennedy on vaccines ahead of midterm elections, making the covert nature of the effort the central news hook.

Factual accuracy — Mostly solid

The piece contains several specific, verifiable claims that appear accurate on their face. The WHO figure — vaccines "saved 154 million lives over the past half-century" — is traceable to a 2024 Lancet study and is correctly attributed to the WHO. The $40–50 million cost estimate is attributed to a single anonymous source, which limits verifiability. The detail that Kulldorff "earned $400 per hour as an expert witness" in the Gardasil case is sourced to court records, a strong basis. The article states thimerosal "has largely been removed from vaccines in the United States but remains in some flu shots" — a factually accurate and appropriately qualified claim.

One verifiable claim is under-sourced: "The preservative has been thoroughly studied and found to be unrelated to autism" is presented as established fact without citing the specific studies. This is defensible as scientific consensus, but a skeptical reader deserves a pointer to the evidence, especially in a piece about contested science. The C.D.C. Vaccine Safety Datalink is described accurately. No outright factual errors are identified.

Framing — Tilted

1. "despite his public silence" (paraphrased in the headline structure, echoed in the lede): The framing casts the inquiry as something to hide, before any evidence of misconduct is presented. The phrase "quest for evidence that they are unsafe" implies predetermined conclusion, which the article attributes to no specific source — it is authorial voice.

2. "cherry-picking data and misinterpreting studies" — these are attributed to "vaccine scholars and critics," which is appropriate attribution, but the article never quotes anyone characterizing the new Kulldorff-led effort specifically in these terms; the critique of Kennedy's prior conduct bleeds into coverage of the current initiative.

3. "resurrects research into a number of ideas Mr. Kennedy has espoused" — "resurrects" and "has espoused" carry connotation of discredited revival; the article does not apply comparable language to CDC's existing surveillance programs for rhetorical symmetry.

4. "riddled with pitfalls" — the article says "Researchers say that such comparison studies would be riddled with pitfalls," but the researchers saying this are unnamed. This is an authorial-voice characterization with vague attribution.

5. The article's final third quotes Dr. Edwards twice and Dr. Jernigan once in explicitly critical terms, with no counter-voice from scientists who believe the new inquiry has scientific merit, even though the piece itself establishes Kulldorff as "a pioneer in methods to examine vaccine safety."

Source balance

Ratio: Named critical voices: 2. Named supportive voices: 2 (Nixon is a spokesman, Wright is not a scientist). Named neutral/mixed: 1. Anonymous sources: 6 (all descriptive, but framing is critical throughout). The six primary sources are all anonymous and none is quoted defending the scientific merit of the new design. No independent vaccine-safety researcher who reviewed the protocol and found it sound is quoted. The ratio of critical to supportive scientific voices is roughly 3:1.

Omissions

1. Prior administration precedent. The article does not note whether previous administrations conducted vaccine-schedule safety reviews or funded vax-unvax-adjacent studies. A reader would want this baseline to assess whether the scale or intent of this effort is genuinely anomalous.

2. Kulldorff's specific research design for the new studies. The article says scientists are conducting "a look at the overall effect of the childhood vaccine schedule" but does not describe the methodology beyond the vax-unvax comparison. Without this, readers cannot assess the methodological criticism independently.

3. The "thoroughly studied" thimerosal claim goes uncited. The Institute of Medicine 2004 report and subsequent studies are the standard references. Readers following Kennedy's argument deserve a citation, not just reassurance.

4. Budget context. The $40–50 million figure is presented without comparison to CDC's existing vaccine safety surveillance budget, making it impossible for readers to judge whether this is a massive reallocation or a marginal addition.

5. The legal strategy angle is introduced but underdeveloped. Kennedy's 2024 podcast quote about building a litigation record is genuinely newsworthy, but the article does not explore whether using federal research funds to build a private litigation record raises legal or ethical questions — a significant omission.

What it does well

• Specific operational detail: The piece names the meeting date ("a daylong meeting on the new vaccine research initiative in late February"), the cost estimate, the lead official, and his oversight structure — grounding an otherwise abstract bureaucratic story in concrete fact.
• "Martin had been known for decades as a top-notch vaccine safety scientist" — the article fairly presents Kulldorff's legitimate credentials before raising concerns about his recent work, avoiding a one-dimensional portrayal.
• "earned $400 per hour as an expert witness, court records show" — the Gardasil conflict-of-interest detail is sourced to court records rather than anonymous testimony, a strong evidentiary choice.
• "A former plaintiff's lawyer, Mr. Kennedy has long said…" — the background paragraph explaining Kennedy's theory of change through litigation usefully contextualizes his motivation without editorializing.
• Bylines are specific and include beat descriptions, giving readers transparency about which reporters cover which agencies.

Rating

Overall: 6/10 — A newsworthy scoop with solid reporting mechanics that is weakened by anonymous-source dependency, unattributed interpretive framing, and a scientific-voice ratio that leaves readers without a credible defender of the initiative's design.